RxDoctor Payments Data

Leonard Maliver, MD

Urology · Indiana, PANPI 1548215353

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,801 of the $9,153 with a category attached, or 63.4%. It is spread thinly across 29 manufacturers, the largest accounting for just 21.5%. Reporting peaked in 2022 at $2,892 and has fallen 94.9% since, to $147 in 2025.

$9,153in general payments, 2019–2025

Across 318 payments — averaging $28.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Medtronic$2K
  • Astellas Pharma US Inc$1K
  • Pfizer$529
  • Cook Medical LLC$526
  • Cook Incorporated$486
  • plus $3K from 23 others
$3,919in research payments, 2019–2025

Across 4 payments — averaging $979.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • OPKO Pharmaceuticals, LLC$4K

What the payments were for

  • Travel & lodging$3,04333%
  • Food & beverage$5,80163%
  • Education$3103%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,153 in reported general payments places this provider in the 80th percentile of 596 urology providers in Pennsylvania.

See all urology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$33,790
Medicare patients
103
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Finasteride65$583
Tamsulosin Hcl34$439
Ciprofloxacin Hcl11$38

Paid to pharmacies, not to this prescriber.

Other urology in Indiana

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →